Channing Smith, portfolio manager at Capital Advisors Growth Fund, told CNBC that Apple is no longer the opportunity it once was.» Read More
According to Forbes, the 1,826 billionaires have a total wealth of $7 trillion, up from $6.4 trillion last year, reports CNBC's Robert Frank.
BlackBerry is looking to put its software on other devices. How to play the stock, with Colin Gillis, BGC Financial.
Bill Gross, Janus Capital Group discusses his take on the NASDAQ hitting 5000 and shares his latest investment outlook.
Signals from China and India on how to invest
Bill Gross, Janus Capital Group discusses his take on negative yields and debt.
Channing Smith, Capital Advisers Growth Fund discusses his take on Apple.
David Rolfe, RiverPark Wedgewood Funds discusses his stake in Berkshire Hathaway.
The USDA says beef prices will rise 5-6 percent for the whole year, which is twice the overall rate of food inflation, reports CNBC's Jane Wells.
"Power Lunch" hosts Melissa Lee and Brian Sullivan look at 5 stocks with analyst recommendations.
CNBC's Jon Fortt reports live from the GSMA Mobile World Congress in Barcelona, Spain and touches on the key takeaways.
CNBC's Jackie DeAngelis tracks oil's mixed action into the close. Iranian comments about a potential nuclear deal put downward pressure on crude.
In Monday's "Power Rundown," CNBC's Julia Boorstin, weighs in on ISIS threatening Twitter, and Samsung releasing the latest version of the Galaxy with a new curved screen.
Hedge funds are on track to top $3 trillion in assets this year. Barry Bausano, Deutsche Bank, discusses what's driving the healthy growth.
Former Federal Reserve Chair Ben Bernanke spoke out on opposing the audit the Fed bill.
Janus Capital's Bill Gross on Monday said the Nasdaq hitting 5,000 represents "a little bit of a bubble."
Deutsche Bank Alternative Asset survey on top hedge fund investment strategies
CNBC's Bertha Coombs checks out which sectors are going strong and those that continue to lag.
Holders of senior debt in an Austrian bank have found out they will lose money, and thousands mourned the assassination of Putin critic Boris Nemtsov, reports CNBC's Michelle Caruso-Cabrera.
Amgen's cancer drug Kyprolis demonstrated positive results in a study against Takeda's Velcade. Dr. Sean Harper, Amgen, discusses the benefit risk equation for both drugs.
Finding value in the market after the Nasdaq briefly touched the 5,000 mark, with Brian Belski, BMO Capital Markets, and Zachary Karabell, Envestnet Global Strategy head.
"Power Pitch" picks the brain of Chris Thompson, who claims his start-up has created the first energy-drink designed to give a boost to your brain.
Todd Mitchem pitches his pot start-up to a panel of experts.
Co-founder Ajay Kori pitches his flower start-up to the "Power Pitch" panel. Will it blossom, or will the panel snip it?